SEC Form 4 · accession 0001144204-15-053289
Harvard Apparatus Regenerative Technology, Inc. · HRGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Saverio LaFrancesca
Officer — Chief Medical Officer
Period of report
Aug 28, 2015
Accepted (ET)
Sep 1, 2015 · 5:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001563665
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 28, 2015 | P | 2,500 | $0.96 | A | 14,214 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $1.40 | Aug 31, 2015 | A | 160,000 | A | — | Aug 31, 2025 | Common Stock, par value $0.01 per share | 160,000 | 160,000 | D |
Explanation of responses
- F1The option shares vest in four equal installments on August 31, 2016, 2017, 2018 and 2019.
Remarks
This form has been signed under power of attorney.